Pamela Peterson
Concepts (434)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 71 | 2025 | 2323 | 5.630 |
Why?
| | Defibrillators, Implantable | 30 | 2022 | 382 | 4.320 |
Why?
| | Cardiac Resynchronization Therapy | 9 | 2022 | 63 | 2.710 |
Why?
| | Cardiovascular Diseases | 19 | 2026 | 2168 | 2.130 |
Why?
| | Sexual Dysfunction, Physiological | 5 | 2026 | 74 | 2.120 |
Why?
| | Registries | 46 | 2025 | 2385 | 2.110 |
Why?
| | Ventricular Dysfunction, Left | 13 | 2023 | 392 | 1.970 |
Why?
| | Stroke Volume | 27 | 2024 | 651 | 1.910 |
Why?
| | Cardiac Rehabilitation | 4 | 2025 | 46 | 1.860 |
Why?
| | Death, Sudden, Cardiac | 15 | 2019 | 230 | 1.860 |
Why?
| | Hospitalization | 32 | 2024 | 2433 | 1.830 |
Why?
| | Bradycardia | 3 | 2021 | 59 | 1.740 |
Why?
| | Cancer Survivors | 6 | 2026 | 327 | 1.690 |
Why?
| | Primary Prevention | 12 | 2019 | 220 | 1.560 |
Why?
| | American Heart Association | 18 | 2022 | 350 | 1.540 |
Why?
| | Cardiology | 15 | 2022 | 353 | 1.520 |
Why?
| | Atrial Fibrillation | 8 | 2022 | 550 | 1.430 |
Why?
| | Operating Rooms | 2 | 2024 | 146 | 1.370 |
Why?
| | Aged | 99 | 2026 | 25913 | 1.210 |
Why?
| | Patient Compliance | 5 | 2025 | 588 | 1.160 |
Why?
| | Cardiac Conduction System Disease | 2 | 2018 | 3 | 1.160 |
Why?
| | United States | 77 | 2025 | 15966 | 1.150 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 102 | 1.140 |
Why?
| | Cardiac Pacing, Artificial | 2 | 2018 | 84 | 1.100 |
Why?
| | Medicare | 20 | 2024 | 886 | 1.100 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 10 | 2023 | 221 | 1.090 |
Why?
| | Myocardial Infarction | 19 | 2018 | 1209 | 1.070 |
Why?
| | Patient Readmission | 11 | 2024 | 758 | 1.070 |
Why?
| | Text Messaging | 6 | 2026 | 182 | 1.050 |
Why?
| | Healthcare Disparities | 7 | 2021 | 727 | 1.040 |
Why?
| | Practice Guidelines as Topic | 16 | 2019 | 1560 | 1.020 |
Why?
| | Humans | 172 | 2026 | 144759 | 1.020 |
Why?
| | Disposable Equipment | 2 | 2024 | 24 | 1.010 |
Why?
| | Adrenergic beta-Antagonists | 10 | 2023 | 250 | 0.970 |
Why?
| | Reminder Systems | 4 | 2025 | 141 | 0.920 |
Why?
| | Guideline Adherence | 12 | 2019 | 589 | 0.870 |
Why?
| | Medication Adherence | 9 | 2026 | 539 | 0.870 |
Why?
| | Male | 107 | 2026 | 72315 | 0.860 |
Why?
| | Female | 110 | 2026 | 78271 | 0.850 |
Why?
| | Practice Patterns, Physicians' | 11 | 2020 | 1356 | 0.810 |
Why?
| | Ventricular Function, Left | 7 | 2021 | 541 | 0.790 |
Why?
| | Surgeons | 3 | 2022 | 339 | 0.790 |
Why?
| | Aged, 80 and over | 41 | 2026 | 8265 | 0.740 |
Why?
| | Secondary Prevention | 6 | 2017 | 254 | 0.740 |
Why?
| | Home Care Services | 2 | 2025 | 280 | 0.740 |
Why?
| | Patient Discharge | 16 | 2024 | 983 | 0.730 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 94 | 0.720 |
Why?
| | Behavior Therapy | 1 | 2025 | 299 | 0.710 |
Why?
| | Health Status Disparities | 3 | 2021 | 321 | 0.700 |
Why?
| | Cardiac Resynchronization Therapy Devices | 3 | 2020 | 18 | 0.690 |
Why?
| | Middle Aged | 63 | 2026 | 35875 | 0.690 |
Why?
| | Anemia | 4 | 2020 | 188 | 0.670 |
Why?
| | Angiotensin Receptor Antagonists | 11 | 2023 | 114 | 0.650 |
Why?
| | Retrospective Studies | 36 | 2025 | 17066 | 0.650 |
Why?
| | Neoplasms | 6 | 2026 | 2875 | 0.630 |
Why?
| | Anti-Arrhythmia Agents | 4 | 2022 | 142 | 0.620 |
Why?
| | Peripheral Arterial Disease | 2 | 2024 | 503 | 0.600 |
Why?
| | Hospitals | 7 | 2021 | 730 | 0.570 |
Why?
| | Heart Block | 1 | 2018 | 40 | 0.570 |
Why?
| | Ventricular Function | 1 | 2018 | 57 | 0.550 |
Why?
| | Risk Factors | 30 | 2024 | 10779 | 0.550 |
Why?
| | Heart Conduction System | 1 | 2018 | 95 | 0.550 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 24 | 0.550 |
Why?
| | Heart Failure, Systolic | 1 | 2018 | 27 | 0.540 |
Why?
| | Cardiologists | 1 | 2018 | 47 | 0.540 |
Why?
| | Birth Certificates | 1 | 2017 | 12 | 0.530 |
Why?
| | Risk Assessment | 15 | 2021 | 3671 | 0.530 |
Why?
| | Medicaid | 3 | 2021 | 461 | 0.520 |
Why?
| | Stroke | 3 | 2024 | 1256 | 0.520 |
Why?
| | Pregnancy Trimester, First | 1 | 2017 | 136 | 0.510 |
Why?
| | Congresses as Topic | 1 | 2018 | 221 | 0.510 |
Why?
| | Aminobutyrates | 6 | 2023 | 31 | 0.500 |
Why?
| | Appointments and Schedules | 1 | 2017 | 97 | 0.490 |
Why?
| | Hospital Mortality | 8 | 2024 | 1030 | 0.490 |
Why?
| | Decision Support Techniques | 5 | 2022 | 456 | 0.480 |
Why?
| | Clinical Decision-Making | 3 | 2018 | 359 | 0.480 |
Why?
| | Treatment Outcome | 28 | 2026 | 11679 | 0.480 |
Why?
| | Social Determinants of Health | 1 | 2020 | 301 | 0.470 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 134 | 0.460 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1326 | 0.450 |
Why?
| | Advisory Committees | 8 | 2022 | 228 | 0.450 |
Why?
| | Prenatal Care | 1 | 2017 | 307 | 0.440 |
Why?
| | Age Factors | 11 | 2020 | 3333 | 0.440 |
Why?
| | Waiting Lists | 1 | 2017 | 263 | 0.430 |
Why?
| | Patient Participation | 4 | 2022 | 431 | 0.430 |
Why?
| | Quality of Health Care | 6 | 2012 | 691 | 0.430 |
Why?
| | Outpatients | 4 | 2021 | 442 | 0.420 |
Why?
| | Critical Care | 2 | 2018 | 695 | 0.420 |
Why?
| | Cohort Studies | 21 | 2019 | 5960 | 0.420 |
Why?
| | Health Status Indicators | 3 | 2015 | 166 | 0.410 |
Why?
| | Decision Making | 7 | 2022 | 975 | 0.410 |
Why?
| | Cardiovascular Agents | 3 | 2025 | 164 | 0.410 |
Why?
| | Hemoglobins | 3 | 2020 | 384 | 0.400 |
Why?
| | Electrocardiography | 7 | 2021 | 662 | 0.400 |
Why?
| | Insurance Coverage | 3 | 2021 | 239 | 0.390 |
Why?
| | Heart | 4 | 2023 | 636 | 0.380 |
Why?
| | Biphenyl Compounds | 6 | 2023 | 68 | 0.380 |
Why?
| | Health Literacy | 2 | 2014 | 184 | 0.370 |
Why?
| | Heart-Assist Devices | 1 | 2018 | 567 | 0.360 |
Why?
| | Electric Countershock | 3 | 2019 | 127 | 0.360 |
Why?
| | Acculturation | 1 | 2012 | 54 | 0.350 |
Why?
| | Glomerular Filtration Rate | 3 | 2024 | 760 | 0.350 |
Why?
| | Time Factors | 16 | 2024 | 7173 | 0.350 |
Why?
| | Stress, Psychological | 1 | 2020 | 1152 | 0.350 |
Why?
| | Diabetes Mellitus | 5 | 2023 | 1098 | 0.340 |
Why?
| | Valsartan | 5 | 2022 | 32 | 0.340 |
Why?
| | Minority Groups | 2 | 2021 | 282 | 0.340 |
Why?
| | Coronary Artery Disease | 3 | 2013 | 741 | 0.340 |
Why?
| | Health Status | 6 | 2012 | 836 | 0.330 |
Why?
| | Inpatients | 3 | 2023 | 545 | 0.330 |
Why?
| | Tetrazoles | 5 | 2023 | 50 | 0.320 |
Why?
| | Quality of Life | 13 | 2024 | 3185 | 0.320 |
Why?
| | Coronary Disease | 3 | 2008 | 383 | 0.320 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2025 | 1720 | 0.320 |
Why?
| | Young Adult | 11 | 2026 | 14105 | 0.320 |
Why?
| | Drug Monitoring | 3 | 2026 | 395 | 0.320 |
Why?
| | Heart Transplantation | 1 | 2017 | 736 | 0.320 |
Why?
| | Arrhythmias, Cardiac | 3 | 2019 | 361 | 0.310 |
Why?
| | Pragmatic Clinical Trials as Topic | 3 | 2026 | 133 | 0.310 |
Why?
| | Health Behavior | 2 | 2026 | 785 | 0.300 |
Why?
| | Hospitals, Pediatric | 2 | 2024 | 556 | 0.300 |
Why?
| | Health Services Accessibility | 1 | 2017 | 1098 | 0.290 |
Why?
| | Metformin | 2 | 2023 | 318 | 0.290 |
Why?
| | Sex Factors | 8 | 2018 | 2112 | 0.280 |
Why?
| | Catheter Ablation | 1 | 2012 | 353 | 0.270 |
Why?
| | Physician-Patient Relations | 4 | 2021 | 585 | 0.260 |
Why?
| | Neprilysin | 4 | 2021 | 47 | 0.260 |
Why?
| | Equipment Design | 4 | 2017 | 530 | 0.250 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2023 | 653 | 0.250 |
Why?
| | Adult | 24 | 2026 | 40449 | 0.240 |
Why?
| | Aftercare | 6 | 2023 | 223 | 0.240 |
Why?
| | Ventricular Remodeling | 2 | 2018 | 276 | 0.240 |
Why?
| | Quality Improvement | 4 | 2021 | 1289 | 0.240 |
Why?
| | Survivors | 2 | 2009 | 520 | 0.240 |
Why?
| | Multicenter Studies as Topic | 3 | 2026 | 405 | 0.240 |
Why?
| | Follow-Up Studies | 13 | 2021 | 5408 | 0.230 |
Why?
| | Exercise Tolerance | 1 | 2008 | 283 | 0.230 |
Why?
| | Ambulatory Care | 2 | 2025 | 600 | 0.230 |
Why?
| | Cross-Sectional Studies | 11 | 2022 | 5868 | 0.230 |
Why?
| | Adolescent | 9 | 2026 | 22428 | 0.220 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2024 | 439 | 0.220 |
Why?
| | Mineralocorticoid Receptor Antagonists | 3 | 2020 | 68 | 0.220 |
Why?
| | Kidney Diseases | 1 | 2009 | 427 | 0.220 |
Why?
| | Self Care | 4 | 2018 | 389 | 0.220 |
Why?
| | Prone Position | 1 | 2005 | 24 | 0.220 |
Why?
| | Atherosclerosis | 2 | 2024 | 409 | 0.220 |
Why?
| | Supine Position | 1 | 2005 | 37 | 0.220 |
Why?
| | Social Support | 5 | 2014 | 652 | 0.220 |
Why?
| | Exercise Test | 4 | 2008 | 634 | 0.220 |
Why?
| | Diabetes Complications | 1 | 2006 | 222 | 0.220 |
Why?
| | Evidence-Based Medicine | 4 | 2013 | 732 | 0.220 |
Why?
| | Heart Diseases | 1 | 2008 | 349 | 0.210 |
Why?
| | Child | 7 | 2024 | 22633 | 0.210 |
Why?
| | Insurance, Health | 2 | 2017 | 302 | 0.210 |
Why?
| | Informed Consent | 2 | 2023 | 198 | 0.210 |
Why?
| | Quality Assurance, Health Care | 4 | 2010 | 340 | 0.210 |
Why?
| | Artifacts | 1 | 2005 | 139 | 0.210 |
Why?
| | Survival Analysis | 6 | 2019 | 1382 | 0.210 |
Why?
| | Cardiovascular Abnormalities | 1 | 2024 | 15 | 0.210 |
Why?
| | Postoperative Complications | 2 | 2024 | 2919 | 0.210 |
Why?
| | Risk Reduction Behavior | 1 | 2026 | 226 | 0.200 |
Why?
| | Survival Rate | 7 | 2019 | 2089 | 0.200 |
Why?
| | Image Enhancement | 1 | 2005 | 199 | 0.200 |
Why?
| | Odds Ratio | 7 | 2017 | 1075 | 0.200 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2021 | 38 | 0.200 |
Why?
| | Fee-for-Service Plans | 2 | 2014 | 98 | 0.200 |
Why?
| | Sex Characteristics | 1 | 2009 | 790 | 0.200 |
Why?
| | Risk | 3 | 2019 | 911 | 0.190 |
Why?
| | Predictive Value of Tests | 7 | 2018 | 2115 | 0.190 |
Why?
| | Incidence | 6 | 2019 | 2879 | 0.190 |
Why?
| | Heart Rate | 3 | 2019 | 855 | 0.190 |
Why?
| | Drug Combinations | 5 | 2022 | 390 | 0.190 |
Why?
| | Atherectomy | 1 | 2023 | 37 | 0.190 |
Why?
| | Qualitative Research | 3 | 2021 | 1671 | 0.190 |
Why?
| | Vascular Patency | 1 | 2023 | 121 | 0.190 |
Why?
| | Popliteal Artery | 1 | 2023 | 62 | 0.190 |
Why?
| | Movement | 1 | 2005 | 293 | 0.190 |
Why?
| | Coated Materials, Biocompatible | 1 | 2023 | 65 | 0.190 |
Why?
| | Social Class | 2 | 2017 | 268 | 0.190 |
Why?
| | Depression | 7 | 2024 | 1558 | 0.190 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2022 | 21 | 0.190 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2025 | 2583 | 0.180 |
Why?
| | Refusal to Participate | 1 | 2021 | 6 | 0.180 |
Why?
| | Colorado | 6 | 2017 | 4564 | 0.180 |
Why?
| | Mortality | 4 | 2017 | 375 | 0.180 |
Why?
| | Prognosis | 9 | 2022 | 4282 | 0.180 |
Why?
| | Acute Kidney Injury | 2 | 2024 | 865 | 0.180 |
Why?
| | Multivariate Analysis | 11 | 2017 | 1539 | 0.180 |
Why?
| | Seasons | 1 | 2024 | 556 | 0.180 |
Why?
| | Linear Models | 5 | 2017 | 854 | 0.180 |
Why?
| | Femoral Artery | 1 | 2023 | 190 | 0.170 |
Why?
| | Hospital Costs | 1 | 2022 | 124 | 0.170 |
Why?
| | Adenoidectomy | 1 | 2022 | 81 | 0.170 |
Why?
| | Cardiac Surgical Procedures | 4 | 2010 | 609 | 0.170 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2021 | 64 | 0.170 |
Why?
| | Longitudinal Studies | 5 | 2018 | 2947 | 0.170 |
Why?
| | Surgical Procedures, Operative | 1 | 2024 | 270 | 0.170 |
Why?
| | Manufacturing Industry | 1 | 2020 | 6 | 0.170 |
Why?
| | Chi-Square Distribution | 5 | 2017 | 529 | 0.170 |
Why?
| | Protease Inhibitors | 1 | 2021 | 102 | 0.170 |
Why?
| | Societies, Medical | 4 | 2020 | 887 | 0.160 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 56 | 0.160 |
Why?
| | Hydroxychloroquine | 1 | 2021 | 63 | 0.160 |
Why?
| | Interrupted Time Series Analysis | 1 | 2021 | 75 | 0.160 |
Why?
| | Comorbidity | 7 | 2023 | 1658 | 0.160 |
Why?
| | Prosthesis Implantation | 2 | 2019 | 153 | 0.160 |
Why?
| | Surveys and Questionnaires | 10 | 2022 | 6048 | 0.160 |
Why?
| | Groundwater | 1 | 2021 | 41 | 0.160 |
Why?
| | Health Care Costs | 1 | 2024 | 427 | 0.160 |
Why?
| | Patient Care | 1 | 2021 | 118 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 2 | 2024 | 488 | 0.160 |
Why?
| | Confidence Intervals | 2 | 2012 | 333 | 0.160 |
Why?
| | Clinical Trials as Topic | 4 | 2015 | 1053 | 0.160 |
Why?
| | Goals | 2 | 2020 | 183 | 0.160 |
Why?
| | Organizational Innovation | 1 | 2020 | 120 | 0.150 |
Why?
| | Exercise | 3 | 2009 | 2201 | 0.150 |
Why?
| | Prospective Studies | 11 | 2018 | 7990 | 0.150 |
Why?
| | Research Personnel | 1 | 2021 | 186 | 0.150 |
Why?
| | Income | 1 | 2020 | 202 | 0.150 |
Why?
| | Algorithms | 2 | 2021 | 1837 | 0.150 |
Why?
| | Schools, Medical | 1 | 2020 | 156 | 0.150 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2020 | 62 | 0.150 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 187 | 0.150 |
Why?
| | Intensive Care Units | 2 | 2018 | 916 | 0.150 |
Why?
| | Hypertension | 3 | 2021 | 1263 | 0.150 |
Why?
| | Length of Stay | 3 | 2024 | 1337 | 0.140 |
Why?
| | Logistic Models | 7 | 2015 | 2117 | 0.140 |
Why?
| | Antirheumatic Agents | 1 | 2021 | 304 | 0.140 |
Why?
| | Fraud | 1 | 2018 | 10 | 0.140 |
Why?
| | Personal Satisfaction | 1 | 2020 | 222 | 0.140 |
Why?
| | Multimorbidity | 1 | 2019 | 63 | 0.140 |
Why?
| | Research Design | 2 | 2023 | 1135 | 0.140 |
Why?
| | Medical Overuse | 1 | 2018 | 30 | 0.140 |
Why?
| | Minority Health | 1 | 2018 | 18 | 0.140 |
Why?
| | Computers, Handheld | 1 | 2018 | 26 | 0.140 |
Why?
| | Hospitals, Rural | 1 | 2018 | 51 | 0.130 |
Why?
| | Social Values | 1 | 2018 | 40 | 0.130 |
Why?
| | Patient Selection | 4 | 2021 | 719 | 0.130 |
Why?
| | Subacute Care | 1 | 2018 | 82 | 0.130 |
Why?
| | Hospitals, Urban | 1 | 2018 | 144 | 0.130 |
Why?
| | Bundle-Branch Block | 2 | 2017 | 36 | 0.130 |
Why?
| | Treatment Refusal | 2 | 2008 | 98 | 0.130 |
Why?
| | Efficiency, Organizational | 1 | 2018 | 139 | 0.130 |
Why?
| | Faculty, Medical | 1 | 2020 | 302 | 0.130 |
Why?
| | Coronary Angiography | 3 | 2008 | 323 | 0.130 |
Why?
| | Burns | 1 | 2022 | 377 | 0.130 |
Why?
| | Cause of Death | 3 | 2019 | 471 | 0.120 |
Why?
| | Publishing | 1 | 2018 | 114 | 0.120 |
Why?
| | Thromboembolism | 1 | 2017 | 125 | 0.120 |
Why?
| | Prosthesis Design | 1 | 2018 | 357 | 0.120 |
Why?
| | Warfarin | 1 | 2017 | 170 | 0.120 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 463 | 0.120 |
Why?
| | Medically Uninsured | 1 | 2017 | 129 | 0.120 |
Why?
| | Prevalence | 5 | 2022 | 2834 | 0.120 |
Why?
| | Nurse Practitioners | 1 | 2018 | 140 | 0.120 |
Why?
| | Quality Indicators, Health Care | 1 | 2018 | 335 | 0.120 |
Why?
| | Proportional Hazards Models | 4 | 2019 | 1325 | 0.110 |
Why?
| | Racism | 1 | 2018 | 151 | 0.110 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2021 | 543 | 0.110 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2018 | 299 | 0.110 |
Why?
| | Health Policy | 1 | 2017 | 400 | 0.100 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 1185 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 760 | 0.100 |
Why?
| | Cardiotonic Agents | 1 | 2014 | 95 | 0.100 |
Why?
| | Systole | 2 | 2013 | 178 | 0.100 |
Why?
| | Consensus | 3 | 2022 | 488 | 0.100 |
Why?
| | Mental Health | 1 | 2020 | 790 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2020 | 1414 | 0.100 |
Why?
| | Hyperkalemia | 1 | 2013 | 35 | 0.100 |
Why?
| | Kidney | 1 | 2021 | 1495 | 0.100 |
Why?
| | Hemodialysis Units, Hospital | 1 | 2012 | 5 | 0.100 |
Why?
| | Severity of Illness Index | 3 | 2010 | 2925 | 0.090 |
Why?
| | Medical Staff | 1 | 2012 | 17 | 0.090 |
Why?
| | Vascular Access Devices | 1 | 2012 | 30 | 0.090 |
Why?
| | Software | 1 | 2018 | 690 | 0.090 |
Why?
| | Infant | 2 | 2024 | 10034 | 0.090 |
Why?
| | Anticoagulants | 1 | 2017 | 722 | 0.090 |
Why?
| | Models, Educational | 1 | 2012 | 89 | 0.090 |
Why?
| | Physicians | 1 | 2020 | 939 | 0.090 |
Why?
| | Antihypertensive Agents | 2 | 2023 | 510 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 2 | 2016 | 965 | 0.090 |
Why?
| | Child, Preschool | 2 | 2024 | 11787 | 0.090 |
Why?
| | Forecasting | 2 | 2024 | 391 | 0.090 |
Why?
| | Angina Pectoris | 2 | 2010 | 75 | 0.090 |
Why?
| | Evidence-Based Practice | 2 | 2013 | 238 | 0.090 |
Why?
| | Communication | 1 | 2018 | 965 | 0.090 |
Why?
| | Drug Prescriptions | 1 | 2013 | 284 | 0.080 |
Why?
| | Vocabulary | 1 | 2011 | 35 | 0.080 |
Why?
| | Peripheral Vascular Diseases | 1 | 2011 | 104 | 0.080 |
Why?
| | Cost-Benefit Analysis | 2 | 2026 | 634 | 0.080 |
Why?
| | Managed Care Programs | 1 | 2011 | 138 | 0.080 |
Why?
| | Ambulatory Care Facilities | 1 | 2012 | 265 | 0.080 |
Why?
| | Renin-Angiotensin System | 2 | 2023 | 78 | 0.080 |
Why?
| | Contraindications | 1 | 2010 | 91 | 0.080 |
Why?
| | Bacteremia | 1 | 2012 | 221 | 0.080 |
Why?
| | Women's Health Services | 1 | 2010 | 15 | 0.080 |
Why?
| | Patient-Centered Care | 1 | 2015 | 544 | 0.080 |
Why?
| | Pilot Projects | 3 | 2021 | 1886 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2012 | 465 | 0.080 |
Why?
| | Diuretics | 2 | 2020 | 68 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2009 | 3409 | 0.070 |
Why?
| | Probability | 1 | 2010 | 310 | 0.070 |
Why?
| | Coronary Care Units | 1 | 2007 | 26 | 0.070 |
Why?
| | Myocardial Reperfusion | 1 | 2007 | 59 | 0.070 |
Why?
| | ROC Curve | 1 | 2009 | 614 | 0.070 |
Why?
| | Palliative Care | 2 | 2019 | 1002 | 0.070 |
Why?
| | Women's Health | 1 | 2010 | 310 | 0.070 |
Why?
| | Chest Pain | 1 | 2007 | 99 | 0.060 |
Why?
| | Research Report | 2 | 2017 | 87 | 0.060 |
Why?
| | Emotions | 1 | 2012 | 578 | 0.060 |
Why?
| | Myocardial Ischemia | 2 | 2019 | 285 | 0.060 |
Why?
| | Mass Screening | 2 | 2026 | 1347 | 0.060 |
Why?
| | Emergency Service, Hospital | 2 | 2010 | 2310 | 0.060 |
Why?
| | Angina, Unstable | 1 | 2006 | 82 | 0.060 |
Why?
| | Health Personnel | 1 | 2012 | 748 | 0.060 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 54 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 380 | 0.060 |
Why?
| | Renal Dialysis | 2 | 2024 | 462 | 0.060 |
Why?
| | Caregivers | 1 | 2014 | 1049 | 0.060 |
Why?
| | Weight Loss | 2 | 2009 | 836 | 0.060 |
Why?
| | Sickness Impact Profile | 1 | 2005 | 62 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2006 | 175 | 0.060 |
Why?
| | Physical Endurance | 1 | 2006 | 278 | 0.060 |
Why?
| | Heart Valves | 1 | 2005 | 43 | 0.050 |
Why?
| | Radionuclide Imaging | 1 | 2005 | 112 | 0.050 |
Why?
| | New York | 1 | 2024 | 125 | 0.050 |
Why?
| | Pregnancy | 1 | 2017 | 7190 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2007 | 387 | 0.050 |
Why?
| | Recovery of Function | 1 | 2008 | 707 | 0.050 |
Why?
| | Weight Gain | 1 | 2007 | 556 | 0.050 |
Why?
| | Acute Disease | 1 | 2006 | 1030 | 0.050 |
Why?
| | Electronic Health Records | 1 | 2011 | 1173 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 285 | 0.050 |
Why?
| | Overweight | 1 | 2007 | 609 | 0.050 |
Why?
| | Sodium | 1 | 2023 | 197 | 0.050 |
Why?
| | Patients | 1 | 2024 | 180 | 0.050 |
Why?
| | Biomedical Research | 1 | 2008 | 710 | 0.040 |
Why?
| | Adhesives | 1 | 2021 | 15 | 0.040 |
Why?
| | Tissue Adhesions | 1 | 2021 | 34 | 0.040 |
Why?
| | Population Health | 1 | 2021 | 44 | 0.040 |
Why?
| | Disease Management | 2 | 2017 | 645 | 0.040 |
Why?
| | Medical Oncology | 1 | 2024 | 332 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 36 | 0.040 |
Why?
| | Transferrins | 1 | 2020 | 1 | 0.040 |
Why?
| | Transferrin | 1 | 2020 | 50 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 467 | 0.040 |
Why?
| | Ferritins | 1 | 2020 | 69 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1985 | 0.040 |
Why?
| | Trust | 1 | 2021 | 153 | 0.040 |
Why?
| | Intestines | 1 | 2022 | 358 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 323 | 0.040 |
Why?
| | Health Care Surveys | 2 | 2010 | 539 | 0.040 |
Why?
| | United States Government Agencies | 1 | 2018 | 5 | 0.040 |
Why?
| | Patient Safety | 2 | 2012 | 347 | 0.040 |
Why?
| | Cardiovascular Nursing | 1 | 2018 | 5 | 0.030 |
Why?
| | Transitional Care | 1 | 2018 | 46 | 0.030 |
Why?
| | Aspirin | 2 | 2015 | 399 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1047 | 0.030 |
Why?
| | F Factor | 1 | 2017 | 4 | 0.030 |
Why?
| | Tachycardia, Ventricular | 1 | 2019 | 181 | 0.030 |
Why?
| | Health Facility Size | 1 | 2017 | 13 | 0.030 |
Why?
| | Focus Groups | 1 | 2020 | 573 | 0.030 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 291 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 386 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 2027 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2017 | 119 | 0.030 |
Why?
| | Telemedicine | 1 | 2026 | 945 | 0.030 |
Why?
| | Cerebrovascular Disorders | 1 | 2017 | 103 | 0.030 |
Why?
| | Biomarkers | 2 | 2017 | 4271 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2020 | 473 | 0.030 |
Why?
| | Information Dissemination | 1 | 2018 | 223 | 0.030 |
Why?
| | Skilled Nursing Facilities | 1 | 2017 | 151 | 0.030 |
Why?
| | Frail Elderly | 1 | 2015 | 134 | 0.030 |
Why?
| | Administration, Oral | 1 | 2017 | 847 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 1003 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1813 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2023 | 1387 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2018 | 704 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 288 | 0.020 |
Why?
| | Potassium | 1 | 2013 | 152 | 0.020 |
Why?
| | Pandemics | 1 | 2022 | 1694 | 0.020 |
Why?
| | Comparative Effectiveness Research | 1 | 2014 | 170 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2014 | 423 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3890 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1486 | 0.020 |
Why?
| | Pacific States | 1 | 2012 | 7 | 0.020 |
Why?
| | New England | 1 | 2012 | 37 | 0.020 |
Why?
| | Health Maintenance Organizations | 1 | 2012 | 104 | 0.020 |
Why?
| | Drug Utilization Review | 1 | 2012 | 61 | 0.020 |
Why?
| | Propensity Score | 1 | 2014 | 367 | 0.020 |
Why?
| | Education | 1 | 2012 | 104 | 0.020 |
Why?
| | Hemorrhage | 1 | 2017 | 809 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1907 | 0.020 |
Why?
| | Creatinine | 1 | 2013 | 506 | 0.020 |
Why?
| | Internationality | 1 | 2012 | 156 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2013 | 289 | 0.020 |
Why?
| | Dementia | 1 | 2015 | 303 | 0.020 |
Why?
| | Recurrence | 1 | 2015 | 1135 | 0.020 |
Why?
| | History, 21st Century | 1 | 2012 | 219 | 0.020 |
Why?
| | Needs Assessment | 1 | 2014 | 404 | 0.020 |
Why?
| | Drug Utilization | 1 | 2012 | 166 | 0.020 |
Why?
| | History, 20th Century | 1 | 2012 | 325 | 0.020 |
Why?
| | Infection Control | 1 | 2012 | 172 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 497 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2012 | 126 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 521 | 0.020 |
Why?
| | Lung Diseases | 1 | 2017 | 787 | 0.020 |
Why?
| | Poisson Distribution | 1 | 2010 | 78 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6429 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2009 | 68 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 255 | 0.020 |
Why?
| | Terminal Care | 1 | 2012 | 279 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 920 | 0.020 |
Why?
| | Myocardial Revascularization | 1 | 2008 | 85 | 0.020 |
Why?
| | Databases as Topic | 1 | 2007 | 71 | 0.020 |
Why?
| | Blood Pressure Determination | 1 | 2008 | 144 | 0.020 |
Why?
| | Reperfusion | 1 | 2006 | 54 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2009 | 301 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2009 | 538 | 0.010 |
Why?
| | California | 1 | 2006 | 475 | 0.010 |
Why?
| | Family | 1 | 2009 | 679 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2010 | 851 | 0.010 |
Why?
| | Clinical Competence | 1 | 2012 | 1244 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2007 | 901 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 439 | 0.010 |
Why?
| | Coronary Artery Bypass | 1 | 2005 | 268 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2009 | 947 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2009 | 826 | 0.010 |
Why?
| | Anxiety | 1 | 2009 | 1109 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1273 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1769 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 2327 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 2438 | 0.010 |
Why?
| | Obesity | 1 | 2007 | 3077 | 0.010 |
Why?
|
|
Peterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|